January 13, 2021 After a big year, biotech flotations have much to do Whether investor enthusiasm for drug stocks holds up this year is the burning question for IPO followers.
December 09, 2020 Ash 2020 movers – shorts roasting on an open fire IGM’s snowballing share price belies some other major Ash winners, and will make Christmas unhappy for funds that had shorted the stock.
December 05, 2020 Ash 2020 – efficacy and deaths mark the Car-T multiple myeloma race The latest showing from Car-T players in multiple myeloma sees Johnson & Johnson beat Bluebird, but toxicity hangs over both.
November 26, 2020 Ash 2020 cell therapy preview – the battle for recognition With many of the usual targets on display Fate, Celyad, Allovir and others look to maintain momentum.